Literature DB >> 23252864

Crucial role of CD4+CD 25+ FOXP3+ T regulatory cell, interferon-γ and interleukin-16 in malignant and tuberculous pleural effusions.

Lamiaa Ibrahim1, Manal Salah, Azema Abd El Rahman, Amany Zeidan, Maha Ragb.   

Abstract

The differential diagnosis between malignant and tuberculous exudative pleural effusions is an important clinical problem. The aim of current study is to evaluate the frequencies of T-regulatory cells (Treg) on the basis of distinct phenotypes in the differential diagnosis between malignant and tuberculous pleural effusion. In addition, to evaluate Interferon-gamma (IFN- γ) and interleukin-16 (IL-16) levels and their correlation to Treg cells in malignant and tuberculous pleural effusions. Sixty patients with pleural effusion (26 tuberculous and 34 malignant) and 20 healthy controls were included in the study. Pleural fluid and peripheral blood were assessed for frequencies of T regs, IL-16, and IFN-γ. Pleural effusions from both tuberculous and malignant groups represented significantly higher levels (more in TB) for the following cell populations than peripheral blood: total lymphocytes, CD3+lymphocyte, CD4+CD25+lymphocyte and Treg (CD4+ CD25+FoxP3+). Levels of IL-16 and IFN-γ in tuberculous group were significantly higher than that in malignant group. Regulatory T cells, INF-γ and IL-16 are new important tools for differentiation between tuberculous and malignant pleural effusion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23252864     DOI: 10.3109/08820139.2012.736116

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  8 in total

1.  Diagnostic value of pleural interleukin 17 and carcinoembryonic antigen in lung cancer patients with malignant pleural effusions.

Authors:  Chun-Hua Xu; Ping Zhan; Li-Ke Yu; Xiu-Wei Zhang
Journal:  Tumour Biol       Date:  2013-09-26

2.  Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion.

Authors:  Xue Pan; Anyuan Zhong; Yufei Xing; Minhua Shi; Bin Qian; Tong Zhou; Yongjing Chen; Xueguang Zhang
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

3.  High IL-35 pleural expression in patients with tuberculous pleural effusion.

Authors:  Xuan Dong; Jiong Yang
Journal:  Med Sci Monit       Date:  2015-05-03

Review 4.  Epidemiologic Evidence of and Potential Mechanisms by Which Second-Hand Smoke Causes Predisposition to Latent and Active Tuberculosis.

Authors:  Xiyuan Bai; Shanae L Aerts; Deepshikha Verma; Diane J Ordway; Edward D Chan
Journal:  Immune Netw       Date:  2018-06-26       Impact factor: 6.303

5.  A meta-analysis of Th1 and Th2 cytokine profiles differentiating tuberculous from malignant pleural effusion.

Authors:  Yulin Zeng; Liwei Wang; Hai Zhou; Yu Qi
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

6.  T Helper Cell Subsets in the Pleural Fluid of Tuberculous Patients Differentiate Patients With Non-Tuberculous Pleural Effusions.

Authors:  Neda Dalil Roofchayee; Ian M Adcock; Majid Marjani; Neda K Dezfuli; Mohammad Varahram; Johan Garssen; Esmaeil Mortaz
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

7.  Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients.

Authors:  ChunHua Xu; LiKe Yu; Ping Zhan; Yu Zhang
Journal:  Eur J Med Res       Date:  2014-05-08       Impact factor: 2.175

8.  Transcript levels of major interleukins in relation to the clinicopathological profile of patients with tuberculous intervertebral discs and healthy controls.

Authors:  Chong Liu; Xinli Zhan; Zengming Xiao; Qie Fan; Li Deng; Mingxing Cui; Chunxiang Xiong; Jingbo Xue; Xiangtao Xie
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.